| 产品名称 | 产品编号 | CAS编号 | 分子式 = 分子量 | 位单 | 联系QQ |
| 7alpha-羟基豆甾醇; 7alpha-Hydroxystigmasterol | CFN97114 | 64998-19-2 | C29H48O2 = 428.7 | 5mg | QQ客服：2056216494 |
| 重楼皂苷VII; Chonglou Saponin VII | CFN97162 | 68124-04-9 | C51H82O21 = 1031.2 | 20mg | QQ客服：2159513211 |
| 黄夹次甙乙; 17alpha-Neriifolin | CFN97195 | 7044-31-7 | C30H46O8 = 534.7 | 5mg | QQ客服：1457312923 |
| 通光藤苷元乙; Tenacigenin B | CFN97282 | 80508-42-5 | C21H32O5 = 364.5 | 5mg | QQ客服：1457312923 |
| 豆甾醇; Stigmasterol | CFN97326 | 83-48-7 | C29H48O = 412.7 | 20mg | QQ客服：1457312923 |
| 青阳参苷元; Qingyangshengenin | CFN97401 | 84745-94-8 | C28H36O8 = 500.6 | 20mg | QQ客服：3257982914 |
| 豆甾-4,25-二烯-3-酮; Stigmasta-4,25-dien-3-one | CFN97407 | 848669-08-9 | C29H46O = 410.7 | 5mg | QQ客服：2159513211 |
| 豆甾-4,22,25-三烯-3-酮; Stigmasta-4,22,25-trien-3-one | CFN97408 | 848669-09-0 | C29H44O = 408.7 | 5mg | QQ客服：1457312923 |
| 华蟾素; Cinobufotalin | CFN90137 | 1108-68-5 | C26H34O7 = 458.54 | 20mg | QQ客服：2159513211 |
| 伪异沙蟾毒精; Bufarenogin | CFN90151 | 17008-65-0 | C24H32O6 = 416.51 | 5mg | QQ客服：1413575084 |
| 3,5,9-三羟基麦角甾-7,22-二烯-6-酮; 3,5,9-Trihydroxyergosta-7,22-dien-6-one | CFN97449 | 88191-14-4 | C28H44O4 = 444.7 | 5mg | QQ客服：2056216494 |
| (7Alpha,22R)-7,22,27-三羟基-1-氧代麦角甾烷-2,5,24-三烯-26-酸内酯; Daturataturin A aglycone | CFN97467 | 904665-71-0 | C28H38O5 = 454.6 | 5mg | QQ客服：215959384 |
| 白曼陀罗素; Daturametelin I | CFN97468 | 904667-65-8 | C34H48O10 = 616.8 | 5mg | QQ客服：215959384 |
| 通光散苷A; Tenacigenoside A | CFN97482 | 920502-42-7 | C35H56O12 = 668.8 | 5mg | QQ客服：3257982914 |
| 21-去氧基欧奕二烯酮; 21-Deoxyneridienone B | CFN97487 | 924910-83-8 | C21H28O3 = 328.5 | 5mg | QQ客服：1413575084 |
Cell. 2018 Jan 11;172(1-2):249-261.e12. doi: 10.1016/j.cell.2017.12.019.IF=36.216(2019)
Cell Metab. 2020 Mar 3;31(3):534-548.e5. doi: 10.1016/j.cmet.2020.01.002.IF=22.415(2019)
Mol Cell. 2017 Nov 16;68(4):673-685.e6. doi: 10.1016/j.molcel.2017.10.022.IF=14.548(2019)
ACS Nano. 2018 Apr 24;12(4): 3385-3396. doi: 10.1021/acsnano.7b08969.IF=13.903(2019)
Nature Plants. 2016 Dec 22;3: 16206. doi: 10.1038/nplants.2016.205.IF=13.297(2019)
Sci Adv. 2018 Oct 24;4(10): eaat6994. doi: 10.1126/sciadv.aat6994.IF=12.804(2019)